PI3K/Akt and MAPK, but not NF-kappa B, signaling pathways are involved in c-MET amplification-induced upregulation of PD-L1 in EGFR-TKIs resistant NSCLC cells. This evidence concerns the gene MET and non-small cell lung carcinoma.